Literature DB >> 7159072

Pharmacokinetics of cefuroxime in infants and children with bacterial meningitis.

M de los A del Rio, D F Chrane, S Shelton, G H McCracken, J D Nelson.   

Abstract

A total of 38 patients with bacterial meningitis received either 50 or 75 mg of cefuroxime per kg of body weight given as a 15-min intravenous infusion during the first to third days of therapy. The mean peak plasma concentrations of cefuroxime after doses of 50 and 75 mg/kg were 105 and 152 micrograms/ml, respectively. In five patients, pharmacokinetic values were determined after multiple doses of 50 mg of cefuroxime per kg every 6 h. The mean peak plasma concentrations were 120 micrograms/ml after the first dose and 130 micrograms/ml after the last dose. The concentrations at 6 h were 3.25 and 11.0 micrograms/ml after the first and last doses, respectively. The elimination half-life was approximately 1.5 h, and the apparent volume of distribution was 650 ml/kg. The plasma clearance rate was 195 to 198 ml/min per 1.73 m2. Penetration into the cerebrospinal fluid, expressed as the ratio of the cerebrospinal fluid to serum areas under the curve times 100, was 6.4% in patients given 50 mg of cefuroxime per kg and 10% in those who received 75 mg/kg. The cerebrospinal bactericidal activity in 27 patients was less than or equal to 1:8; only 2 patients had bactericidal activity of less than or equal to 1:2.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7159072      PMCID: PMC185707          DOI: 10.1128/AAC.22.6.990

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates.

Authors:  A J Sedman; J G Wagner
Journal:  J Pharm Sci       Date:  1976-07       Impact factor: 3.534

2.  Cefuroxime: human pharmacokinetics..

Authors:  R D Foord
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

3.  Meningitis due to chloramphenicol-resistant Haemophilus influenzae type b.

Authors:  A L Kinmonth; C N Storrs; R G Mitchell
Journal:  Br Med J       Date:  1978-03-18

4.  Increased resistance to penicillin of pneumococci isolated from man.

Authors:  D Hansman; H Glasgow; J Sturt; L Devitt; R Douglas
Journal:  N Engl J Med       Date:  1971-01-28       Impact factor: 91.245

5.  Cefamandole and ampicillin therapy in experimental Haemophilus influenzae meningitis.

Authors:  L J Strausbaugh; C D Mandaleris; M A Sande
Journal:  J Infect Dis       Date:  1977-02       Impact factor: 5.226

6.  Relapsing pneumococcal meningitis: isolation of an organism with decreased susceptibility to penicillin G.

Authors:  S Naraqi; G P Kirkpatrick; S Kabins
Journal:  J Pediatr       Date:  1974-11       Impact factor: 4.406

7.  Cephalothin and cephaloridine therapy for bacterial meningitis.

Authors:  L S Fisher; A W Chow; T T Yoshikawa; L B Guze
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391

8.  Penicillin-insensitive pneumococci. Case report and review.

Authors:  G A Ahronheim; B Reich; M I Marks
Journal:  Am J Dis Child       Date:  1979-02

9.  Microbioassay of antimicrobial agents.

Authors:  H J Simon; E J Yin
Journal:  Appl Microbiol       Date:  1970-04

10.  Ampicillin in Haemophilus influenzae meningitis. Clinicopharmacologic evaluation of intramuscular vs intravenous administration.

Authors:  H D Wilson; K C Haltalin
Journal:  Am J Dis Child       Date:  1975-02
View more
  8 in total

1.  Penetration of cefuroxime into ventricular fluid in cerebrospinal fluid shunt infections.

Authors:  M S Edwards; C J Baker; K M Butler; E O Mason; J P Laurent; W R Cheek
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

2.  Penetration of amoxicillin and potassium clavulanate into the cerebrospinal fluid of patients with inflamed meninges.

Authors:  J S Bakken; J N Bruun; P Gaustad; T C Tasker
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

3.  Susceptibility studies of multiply resistant Haemophilus influenzae isolated from pediatric patients and contacts.

Authors:  J Campos; S Garcia-Tornel; I Sanfeliu
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

Review 4.  Cephalosporins in the treatment of meningitis.

Authors:  H C Neu
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 5.  Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.

Authors:  J Singh; B Burr; D Stringham; A Arrieta
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 6.  Are children undergoing cardiac surgery receiving antibiotics at subtherapeutic levels?

Authors:  Jennifer H Huang; Rachel Sunstrom; Myrna Y Munar; Ganesh Cherala; Arthur Legg; Ali J Olyeai; Stephen M Langley
Journal:  J Thorac Cardiovasc Surg       Date:  2014-01-15       Impact factor: 5.209

Review 7.  Clinical pharmacokinetics of newer cephalosporins.

Authors:  M E Klepser; M N Marangos; K B Patel; D P Nicolau; R Quintiliani; C H Nightingale
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

8.  Cefuroxime treatment of bacterial meningitis in infants and children.

Authors:  S Sirinavin; S Chiemchanya; P Visudhipan; S Lolekha
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.